Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection

NACompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
AbscessMethicillin-Resistant Staphylococcus Aureus Infection
Interventions
DRUG

Trim/ Sulfa DS

bactrim DS (800/160) two tablets PO BID x 7 days

DRUG

placebo

matched placebo 2 pills PO BID x 7 days

Trial Locations (1)

78236

Wilford Hall Medical Center, Lackland Air Force Base

Sponsors
All Listed Sponsors
collaborator

U.S. Air Force Office of the Surgeon General

FED

collaborator

Emergency Medicine Foundation

OTHER

lead

59th Medical Wing

FED

NCT00822692 - Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection | Biotech Hunter | Biotech Hunter